A coordinated law enforcement effort among myriad federal, state and local law enforcement agencies in Pennsylvania and New Jersey resulted in the arrests of 48 defendants. Included in those arrested were doctors and medical professionals who, allegedly, submitted over $160 million in fraudulent insurance claims, caused losses of over $800 million and distributed over 3.25 million opioid pills. This law enforcement sweep reached across seven federal districts, including the Eastern District of Pennsylvania.
In the Eastern District of Pennsylvania alone, 17 health care professionals were arrested on September 26 for allegedly submitting over $4 million in fraudulent claims and distributing over 738,000 oxycodone doses in pill mill clinics. Some doctors were charged with unlawful distribution of controlled substances for writing prescriptions that were outside the usual course of professional practice and not for legitimate medical purpose. According the Department of Justice, the FBI’s investigation revealed, that these medical doctors prescribed oxycodone to patients without examination or treatment. Defendants then knowingly submitted fraudulent claims to Medicare, health plans provided by the United States Office of Personnel Management (OPM) and Independent Blue Cross (IBC) for payment.
In Philadelphia, one medical doctor, two unlicensed foreign medical school graduates and a nurse practitioner, were indicted on one count each of health care fraud and conspiracy to distribute controlled substances for an alleged scheme which lasted 4 years. The medical doctor, Neil Anand, owned several non-pharmacy dispensaries which dispensed medications. He owned Anand Medical Investment, Institute of Advanced Medical Surgery and Bucks County Spine and Pain Medicine. The indictment alleged that the dispensaries provided the patients with “goody bags” containing prescription medications based on the patient’s insurance coverage, not medications that the patients needed. It also alleged that the defendants did not provide doses or instruction for usage of the medications and required the patients to accept the medically unnecessary medications before the patient received the prescription of a Schedule II controlled substance. The indictment also alleges that the defendants failed to collect co-payments but required patients to sign a false statement stating that they paid their co-pays. The nurse-practitioner is alleged to have signed blank prescriptions and given them to the unlicensed defendants to prescribe Schedule-II controlled substances. The indictment seeks the forfeiture of the gross proceeds traceable to the alleged criminal activity.
The aggressive law enforcement actions were the result of an extensive collaborative effort of agencies with diverse expertise and focus in pursuing criminal and parallel civil actions against medical professionals and others in an effort curtail fraud and the illicit distribution of opioids. These agencies include: departments of the Health Care Fraud Unit in the Criminal Division’s Fraud Section, and the U.S. Attorney’s Offices for the Eastern District of Pennsylvania and the District of New Jersey, known as the “Newark/Philadelphia Regional Medicare Fraud Strike Force” in addition to the FBI, Department of Health and Human Services – Office of Inspector General (HHS-OIG), United States Postal Service – Office of Inspector General (USPS-OIG), the Office of Personnel Management, the Pennsylvania Office of Attorney General, Drug Enforcement Administration, HHS-OIG, the Pennsylvania Department of State’s Bureau of Enforcement and Investigations, the Chester County District Attorney’s Office, the Eastown Township Police Department and the Philadelphia Police Department.
In addition to those arrests mentioned above, 12 defendants were also charged with possession with intent to distribute a Schedule II controlled substance and aiding and abetting others in a scheme to defraud. These 12 defendants allegedly, knowingly, presented false prescriptions to several pharmacies in Pennsylvania and New Jersey and purchased oxycodone from complicit pharmacists paying a premium fee. They then distributed the pills. Those pharmacists have not yet been charged.
The Department of Justice continues to aggressively prosecute those involved in the opioid crisis. Last week the Department of Justice announced charges against 58 defendants across four federal districts in Texas in a similar fraud scheme and illicit possession of controlled substance with intent to distribute. It is alleged that the Texas prosecutions resulted in a $66 million in losses and 6.2. million pills.
Click here to view additional indictments related to this case.
Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to announce its induction into Mackrell International, a leading international network of independent law firms. Founded in 1987 and comprised of more than 90 member firms in over 60 countries, Mackrell International is recognized by Chambers & Partners as one of the “Leading Global-Wide Law Firm Networks.”… Read more »Read More
On April 23, 2020, Pietragallo Partners Lourdes Sánchez Ridge and Michael A. Morse will present “How the False Claims Act Impacts Municipalities.” The False Claims Act (FCA) has been a tool used against municipalities and a tool used by municipalities. During this presentation, which is a part of the International Municipal Lawyers’ Association (IMLA) annual… Read more »Read More
Pietragallo Gordon Alfano Bosick & Raspanti, LLP Partner Pamela Coyle Brecht will present “The False Claims Act Update” at the Pennsylvania Bar Institute’s (PBI) A Day in Health Law program on October 28, 2020 in Philadelphia, Pennsylvania. A Day on Health Law is a one-day, six-hour spin-off of PBI’s annual Health Law Institute. The Health… Read more »Read More
Partner Michael A. Morse will be speaking at the Health Care Compliance Association‘s 6th Annual Healthcare Enforcement Compliance Conference in November. During the four day conference, attendees will hear first‑hand from government officials about regulatory changes, expectations, and key priorities in the Healthcare Enforcement sector. Attendees can further gain the knowledge and skills needed to… Read more »Read More